B WHA! 15H + OBA SE 1, SHE SATE WOE OP (22) > AUIPOBNS GN: ZEHOOA G22 7WOR DIO BO LO} BROKE SBS CMIIES WATE SIAN > AISOIA! & 4 UE, gS SE Protein BOISE 8 Zeiss Antomereit= AR OISAH Blomorkorkl R= 2 SIOZ eC WHOISDIPI THOIOL ZIRE AHH CIA UROL, OIE 87] PAKEY MD ProteinOl LAB ASHE BM Oe 201 BERLIC, 1) Proton’ Her Sem GEN! Os XO1 oF BREEN? Protein MZ SIRDIA OG! THESE LIMOS GEEIC, 210; LOL Protein ZAHA! 74210) phenowoes SHIGE UZAEH SAI 4 QC BAH BE cell} SY AAW BHIGIE Proteins 2 OIG, 2710) ABB LEE BALE Teta ProteonicsOl OB! 7 BE blonarkerS AMOID S6I71 Mal ProtenES SAGs BS OF SRL » Differential oxoression profiling (eal SEMI Proteomics?! S77 BES! Oli: MER BOSDFIG HEC! ORT M4 BC Proteomics G7 Sit MOCHA WEES AME 20) SABIE PESO NO Hm MSE sS ABIL! SH Tee ONE 4 Qe WOISOVIB Wald XO) SAL, 67, 2 SUSOI 7IAle SEO! SAE AORN EEO! 2. THE TeOl BHA (2) > 71801 912% proteomel=2e1)01 CHS SAO Bini TERI QOWA Olek TROT Sek OL ProteonicsiZEAISOA)cits EME B27} OIE O1R 11 proteome® complexity SBC. 2) #48 LAB MICH Protein: 7 ALIA (@ wide dynomic range in cincentratiom BOI LS UO! SACI SHAE BPE 10°08 BEM EE HIRI BABI VOM BAI Protein ‘onrsetninrennins $2 BABE AE WO OI 2-D gels : bish-content proteomies 20 aoke Of proteome® SAID! BAIA: A ACPI. DIS 18 BR, SIE 20 BRE OEIC 1G OY & GION CIMA SHO: AVAL! SIMONI Ol EMSAM LHS! SMO! RIS DIGOIRIAIS RMQLICL Mass spectrometry (MS) : 2 cis 7ie! ws ate =7Ie: 2O-nelOIAI= SHO] EAD! 7s BE CMAEOL! SAF MAAK EAB > QOECIO, AOI BSH Proteina AEN WOR HIE LE a ASSIS BRT? SB@LIC ‘Ab-based methods : | wo! UROL) BoE @ S IAGO GSS NHS LEO] SWELL, OIC 7MOE oF 01 BAB, CM MDS (10-12) I9UHRI BOI Ths! OF SHIGT SE MAILICE SE SOI HEC BO] BOLIC IRB, QERICITE non-cognate proteinOLt CH mocromoleculesEOI ZEKE MISO ZO] SPIKE AB OE © O87) SA) BBS OX BAB SAGE BANOS OBAOIS MALI BDt multioloxed)+ BUASGHCHS & GO| A700 BLIC, (RADE AEIIAIE SAIN SSTISE ALI! 2a AIT DHNOR OIBIagT ME) A naw class of cotomer “SOMAMer’ (Siow OFf-rate Modified Aotaner 3. 71S 71eO) SS ASHI MSH RIAIBE 24 -> SOMAmer (A= NICKS! Aptamer) (3) 1. Antomer7t $12 MSE! SOMAMero BOI BCH? Dual naturesA Ze BA ‘Aptoner - HAISAO eB offinitu JIN SOMOS BB > Sle SWE AVRISELEXO Ole HHI BEE, * SELEX ~ (SELENE! AlSe! Ut IRS OILY aE EMIS Se offnitull TINIE Zita! SHOE 271 SIBL ABITPIOIC, * SoMAMer = ES AIO Aptomer MCL ~ OI SIE EA CIWSOH We Hah offinty aptomers AIEOOK A CHESHBENEMIAL SO! Tsoi ‘SDK ONA Aotomar SEI: ONA miercarroudi OH quontitiod Ct 2, SOMAmers S3 roteorics biomorkor 24 Jia, 242. EME orofileso| CHR 4I7h THBP Pate Ol TS CKDIGHS AAAS LILI SBC 7-H Sele | IHOL SRI CAD biomarkerd BOOK, STM SEO RMS TIA CAD Diomorkersl SCI. 7 AGF O| 71S CRI AOA ZI BAEOI AEIOIAL HEM Unique orotoinG! sianctures chorccteristicm B2iGHe * QR BHC 4. N@S RB She FQ HII! (8=E + Biomarker AtOH# OA! CKD 2%)oe Aang InP IG Ayes 8 barat raph tpaming are (ay oo “Trnan” Toa 1) SIMO WINE! FHUEIOIS ZHOK SELEX BA (figure1 & tablet) SORE NOR) AHO vee! QUTPE SS BH SELEXON AIBC! Bah ; 4) Principle of multiplex SOMAmer affinity assoy A) Binding staga © mixture of SOMAmers (2:22 biotin + phatclavable aroun + fluorescent tas Sere @ A complex proteomic samsle (plasma. serum, conditioned media, cell Iusates) wilt > cognate & non-cognate SOMAmer-target protein complex StaseiCt B) TEOIAI “# ASE cosnate / D2 non-cognate AEH0IC, SOMAMerOIA L&? H6!E! 2101 UVOH OH 22lt= SOIC,Result5, HE Thee OHH SBSH Bt In addition to the CKD studies described in this poper, we have discovered biomarkers in ¢ variety of orcas, including cancer, cardiovascular conditions,, neurological disease, and infectious diseases. With this technology, the success rate for selecting high-quality aptamers to target proteins rosa from <30% to 90%. This multiplexed proteomics assay has the requisite reproducibility, sensitivity, and range for high-content Proteomics studiesand unbiased biomarker discovery. To date, they have selected high-quality SOMAmersto >1.000, human proteins. These proteins represent a wide range of sizes, physicochemical properties, such as ¢ plrange of 4-11, and biological functions from a variety of molecular pathwcus and gene families. 3. HOLES ser fs es (1) 1) 2 BIE7t SCE = Low limits of detection - 1S Ne 37IO SME BAB 4 BC, = TPM megion LLODILower nit af avantfictian! 2) S81 WTF MC = A broad dynamic range SIE OIS2E 240) D1SdKC 3) ROL HEC = High reoraducibitty = 8BO1 GIDED! BEI arch engine® MERIO¥ 6:1 ONE) biomarkerB WZIBIK Kinetic manipulation ep 3) SOMAmer specificity ‘BBITI= FBO ELASAD! sandwich BANOS SOK X01 OILICE ‘SHLIO! SOMAmer €f OILI0\ anolutels!At)01 ZeHEICt